Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

두경부암에서 항체-약물 중합체

Full metadata record
DC Field Value Language
dc.contributor.author김재욱-
dc.date.accessioned2021-08-11T15:44:28Z-
dc.date.available2021-08-11T15:44:28Z-
dc.date.created2021-06-17-
dc.date.issued2017-
dc.identifier.urihttps://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8172-
dc.description.abstractAntibody-drug conjugates (ADCs) represent a promising therapeutic treatment for cancer patients by combining the antigen-targeting specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of chemotherapeutic drugs. ADCs consist of three components, mAbs specific for ad tumor antigen, a linker species, and a cytotoxic payload. ADCs offer selective delivery of cytotoxic agents into targeted cancer cells, thereby allowing for reduced general cellular cytotoxicity caused by chemotherapeutic agents through antibody mediated specific recognition of tumor antigen. Ideally, in blood, after systemic administration, ADCs are nontoxic. Upon binding of the antibody to the targeted tumor antigen and internalization of the complex into the cancer cell, the drug is then released in its active form and in sufficient quantity to kill the cell. ADCs technology has been an active area of research in recent years, resulting in a number of ADCs in development for various tumor types. ADCs are able to be new treatment options for head and neck cancer. The number of ADCs undergoing clinical trial will further increase, possibly replacing some of the existing mAbs, and becoming the next generation of anticancer biotherapeutics. Korean J Otorhinolaryngol-Head Neck Surg 2017;60(7):331-5-
dc.language한국어-
dc.language.isoko-
dc.publisher대한이비인후과학회-
dc.title두경부암에서 항체-약물 중합체-
dc.title.alternativeAntibody-Drug Conjugates in Head and Neck Cancer-
dc.typeArticle-
dc.contributor.affiliatedAuthor김재욱-
dc.identifier.doi10.3342/kjorl-hns.2017.00031-
dc.identifier.bibliographicCitation대한이비인후-두경부외과학회지, v.60, no.7, pp.331 - 335-
dc.relation.isPartOf대한이비인후-두경부외과학회지-
dc.citation.title대한이비인후-두경부외과학회지-
dc.citation.volume60-
dc.citation.number7-
dc.citation.startPage331-
dc.citation.endPage335-
dc.type.rimsART-
dc.identifier.kciidART002245972-
dc.description.journalClass3-
dc.subject.keywordAuthorAntibody-drug conjugate-
dc.subject.keywordAuthorHead and neck cancer.-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Otorhinolaryngology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE